Announcement on Holding Subsidiary’s Drug Obtaining Approval for Clinical Trial
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 2 pages · Chinese
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that its subsidiary has received approval for a clinical trial of a new drug.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Announcement on Holding Subsidiary’s Drug Obtaining Approval for Clinical Trial
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on 6ix
Follow Shanghai Fosun Pharmaceutical (Group) into a list and get an email when it puts out news.
Follow Shanghai Fosun Pharmaceutical (Group)